Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by SBI Biotech Co., Ltd..
Recruitment status was  Recruiting
Sponsor:
Information provided by:
SBI Biotech Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01035216
First received: December 17, 2009
Last updated: September 26, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)